What are the treatment guidelines for hepatitis C genotype 2 or 3 with compensated cirrhosis following liver transplantation?

Updated: Oct 07, 2019
  • Author: Vinod K Dhawan, MD, FACP, FRCPC, FIDSA; Chief Editor: BS Anand, MD  more...
  • Print

◊ HCV genotype 2 or 3 allograft patients with compensated cirrhosis, regardless of treatment experience

Recommended regimen

  • Daily daclatasvir (60 mg) plus sofosbuvir (400 mg) with a low initial dose of ribavirin (600 mg; increase as tolerated) for 12 weeks

Alternative regimens

  • Daily fixed-dose combination of glecaprevir (300 mg)/pibrentasvir (120 mg) for 12 weeks
  • Daily fixed-dose combination of sofosbuvir (400 mg)/velpatasvir (100 mg) with weight-based ribavirin for 12 weeks

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!